Treatment needs vary among patients with cluster headache, according to a poster presented at the American Headache Society ...

A study presented at American Headache Society Annual Scientific Meeting; June 19-22, 2025; Minneapolis has revealed that ...

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

Final results from the Phase IV PEARL trial show that 66% of patients treated with Ajovy for episodic migraine and more than ...

Among adults with episodic migraine, fasting for 5 to 6 hours a day was linked to 49% higher odds of experiencing a same-day ...

Results showed that 662 patients (90.94%) at the headache clinic and 599 patients (33.96%) at the non-headache clinic were diagnosed with episodic migraine. In addition, 598 patients (82.14%) at ...

Once-daily rimegepant 75 mg is effective and well-tolerated for short-term prevention of fasting-related headache in adults ...

Atogepant 60 mg vs rimegepant and galcanezumab for episodic migraine prevention has superior efficacy, with comparable safety ...

Among children and adolescents with episodic migraine, fremanezumab significantly reduced monthly migraine days.

Nummular headache is a rare headache disorder marked by a coin-shaped pain on the scalp. Learn how it differs from other headache types, how it's diagnosed, and treatment options.

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant ...

The trial’s primary goal was to assess the change in the number of migraine days per month from baseline over the first four weeks.